Glenmede Trust’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-2,000
| Closed | -$1K | – | 2921 |
|
|
2017
Q3 | $1K | Hold |
2,000
| – | – | ﹤0.01% | 2690 |
|
|
2017
Q2 | $0 | Hold |
2,000
| – | – | ﹤0.01% | 2741 |
|
|
2017
Q1 | $0 | Hold |
2,000
| – | – | ﹤0.01% | 2848 |
|
|
2016
Q4 | $0 | Hold |
2,000
| – | – | ﹤0.01% | 2752 |
|
|
2016
Q3 | $0 | Hold |
2,000
| – | – | ﹤0.01% | 2787 |
|
|
2016
Q2 | $0 | Hold |
2,000
| – | – | ﹤0.01% | 2875 |
|
|
2016
Q1 | $0 | Hold |
2,000
| – | – | ﹤0.01% | 2836 |
|
|
2015
Q4 | $0 | Hold |
2,000
| – | – | ﹤0.01% | 2898 |
|
|
2015
Q3 | $0 | Hold |
2,000
| – | – | ﹤0.01% | 2941 |
|
|
2015
Q2 | $1K | Hold |
2,000
| – | – | ﹤0.01% | 2635 |
|
|
2015
Q1 | $1K | Hold |
2,000
| – | – | ﹤0.01% | 2420 |
|
|
2014
Q4 | $1K | Hold |
2,000
| – | – | ﹤0.01% | 2494 |
|
|
2014
Q3 | $1K | Hold |
2,000
| – | – | ﹤0.01% | 2424 |
|
|
2014
Q2 | $2K | Hold |
2,000
| – | – | ﹤0.01% | 2258 |
|
|
2014
Q1 | $3K | Hold |
2,000
| – | – | ﹤0.01% | 2240 |
|
|
2013
Q4 | $3K | Hold |
2,000
| – | – | ﹤0.01% | 2199 |
|
|
2013
Q3 | $4K | Hold |
2,000
| – | – | ﹤0.01% | 2091 |
|
|
2013
Q2 | $5K | Buy |
+2,000
| New | +$5.53K | ﹤0.01% | 2011 |
|
Glenmede Trust's ONCY Position: Q4 2017 in Review
Glenmede Trust sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q4 2017, closing a stake of 2,000 shares — an estimated $1K sold.
Glenmede Trust first reported a position in ONCY in Q2 2013 and held it in 18 quarters. The position peaked at $5K in Q2 2013. 1 fund tracked by Wall St. Rank holds ONCY as of Q4 2017.
- Glenmede Trust reported no remaining ONCOLYTICS BIOTECH INC position as of Q4 2017 after selling out during the quarter.
- Glenmede Trust sold 2,000 ONCOLYTICS BIOTECH INC shares in Q4 2017, an estimated $1K.
- Glenmede Trust first reported a position in ONCOLYTICS BIOTECH INC in Q2 2013 and held it in 18 quarters.
- Glenmede Trust's ONCOLYTICS BIOTECH INC position peaked at $5K in Q2 2013.
- 1 fund tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q4 2017.
Based on Glenmede Trust's 13F filing for Q4 2017, filed 15 Feb 2018.